menu
    • menu

    Company profile for Medivir

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Medivir is a pharmaceutical company focusing on the development and commercialization of innovative treatments for cancer. To do this efficiently and with a high success rate, we bring together a unique combination of clinical development skills, a collaborative culture and an extensive industry experience, with a balanced project portfolio. Medivir is listed on Nasdaq Stockholm's Small Cap list

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MedivirSweden Flag
    Country
    Country
    Sweden
    Address
    Address
    Box 1086 SE-141 22 Huddinge
    Telephone
    Telephone
    +46 (0)8 5468 31 00
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.medivir.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Grants Medivir Orphan Drug Designation For MIV-711
    FDA Grants Medivir Orphan Drug Designation For MIV-711

    27 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-27/fda-grants-medivir-s-miv-711-orphan-drug-designation-for-the-treatment-of-osteogenesis-imperfecta

    PHARMIWEB
    27 Nov 2025
    Share Share
    Medivir Presenting At The Aktiespararnas Stora Aktiedagar
    Medivir Presenting At The Aktiespararnas Stora Aktiedagar

    26 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-26/medivir-presenting-at-the-aktiespararnas-stora-aktiedagar

    PHARMIWEB
    26 Nov 2025
    Share Share
    Medivir Licenses Remetinostat To Biossil In Exclusive Deal
    Medivir Licenses Remetinostat To Biossil In Exclusive Deal

    23 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-23/medivir-enters-exclusive-licensing-agreement-with-biossil-inc-for-remetinostat

    PHARMIWEB
    23 Oct 2025
    Share Share
    Medivir Reports Ph 1b/2a Fostrox + Lenvima Data in Liver Cancer
    Medivir Reports Ph 1b/2a Fostrox + Lenvima Data in Liver Cancer

    20 Feb 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-02-20/medivir-presents-positive-final-phase-1b2a-fostrox-plus-lenvima-data-in-advanced-liver-cancer-at-easl-liver-cancer-summit

    PHARMAWEB
    20 Feb 2025
    Share Share
    Medivir to present at the Pareto Securities Healthcare Conference
    Medivir to present at the Pareto Securities Healthcare Conference

    18 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/medivir-to-present-at-the-pareto-securities-healthcare-conference-302251788.html

    PR NEWSWIRE
    18 Sep 2024
    Share Share
    Medivir's Fostrox + Lenvima Shows Promise In Liver Cancer
    Medivir's Fostrox + Lenvima Shows Promise In Liver Cancer

    16 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/medivirs-fostrox--lenvima-confirm-promise-of-improved-outcomes-in-advanced-liver-cancer-detailed-and-mature-data-presented-at-esmo-302248817.html

    PR NEWSWIRE
    16 Sep 2024
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search